# TAVIST-1
> **NDA020925** · New Drug Application · Sponsor: HALEON US HOLDINGS · Approved 1992-08-21
## Drug
- **FDA Application Number:** NDA020925
- **Application type:** New Drug Application
- **Brand name:** TAVIST-1
- **Generic name:** Clemastine Fumarate
- **Active ingredients:** CLEMASTINE FUMARATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** HALEON US HOLDINGS
- **First approval:** 1992-08-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020925)
---
*MORVS · CC0 1.0*